SMW Free Realtime Trade Alerts -- Fast Moving Stocks < $15 -- Join Today for FREE!!

Alcobra Ltd.
(NASDAQ : ADHD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Loading ADHD News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
-3.60%25.477.6%$380.69m
SHPGShire PLC Sponsored ADR
-1.49%196.590.7%$204.88m
PRGOPerrigo Co. Plc
-2.41%94.943.8%$181.24m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-1.01%128.8310.2%$132.35m
ENDPEndo International Plc
-2.46%21.817.2%$124.52m
MNKMallinckrodt Plc
-3.41%70.004.9%$107.01m
AERIAerie Pharmaceuticals, Inc.
-2.68%38.1016.7%$91.99m
JAZZJazz Pharmaceuticals Plc
-1.50%123.873.2%$81.04m
UTHRUnited Therapeutics Corporation
-0.78%117.7417.1%$68.02m
ICPTIntercept Pharmaceuticals, Inc.
-2.17%164.0416.6%$66.53m
HZNPHorizon Pharma plc
-1.23%18.5510.6%$55.69m
CTLTCatalent Inc
-1.25%25.983.7%$55.08m
RPTPRaptor Pharmaceutical Corp.
0.11%8.976.0%$44.69m
ALRAlere Inc.
0.07%43.232.7%$40.22m
DEPODepomed, Inc.
-3.02%23.7921.8%$39.93m

Company Profile

Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel.